Insider Transactions in Q3 2022 at Biodesix Inc (BDSX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 09
2022
|
Scott Hutton President & CEO |
SELL
Open market or private sale
|
Direct |
13,634
-15.38%
|
$27,268
$2.53 P/Share
|
|
Aug 09
2022
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
SELL
Open market or private sale
|
Direct |
3,533
-5.04%
|
$7,066
$2.53 P/Share
|
|
Aug 09
2022
|
Ryan H Siurek Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,645
-12.76%
|
$3,290
$2.53 P/Share
|
|
Aug 09
2022
|
Robert William Georgantas Iii Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,686
-7.05%
|
$3,372
$2.53 P/Share
|
|
Aug 09
2022
|
Gary Anthony Pestano Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,549
-1.71%
|
$3,098
$2.53 P/Share
|
|
Aug 09
2022
|
Kieran O'Kane Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,673
-12.77%
|
$3,346
$2.53 P/Share
|
|
Aug 08
2022
|
Scott Hutton President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,777
+33.56%
|
-
|
|
Aug 08
2022
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,575
+14.18%
|
-
|
|
Aug 08
2022
|
Ryan H Siurek Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,484
+29.85%
|
-
|
|
Aug 08
2022
|
Robert William Georgantas Iii Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,647
+19.09%
|
-
|
|
Aug 08
2022
|
Gary Anthony Pestano Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,054
+5.27%
|
-
|
|
Aug 08
2022
|
Kieran O'Kane Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,462
+29.42%
|
-
|